{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T05:57:33Z","timestamp":1788587853195,"version":"build-2803163510"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T00:00:00Z","timestamp":1694736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K08DA049905"],"award-info":[{"award-number":["K08DA049905"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1007\/s11606-023-08411-0","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T18:02:22Z","timestamp":1694800942000},"page":"385-392","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["In-Hospital Methadone Enrollment: a Novel Program to Facilitate Linkage from the Hospital to the Opioid Treatment Program for Vulnerable Patients with Opioid Use Disorder"],"prefix":"10.1007","volume":"39","author":[{"given":"Susan L.","family":"Calcaterra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Saunders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Grimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Maki-Gianani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Keniston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angi","family":"Wold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Bonaguidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,15]]},"reference":[{"key":"8411_CR1","unstructured":"Ahmad FB CJ, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics. 2023. https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm. Accessed 21 Aug 2023."},{"key":"8411_CR2","doi-asserted-by":"publisher","unstructured":"Singh JA, Cleveland JD. National U.S. time-trends in opioid use disorder hospitalizations and associated healthcare utilization and mortality. PLoS ONE. 2020;15(2):e0229174. https:\/\/doi.org\/10.1371\/journal.pone.0229174.","DOI":"10.1371\/journal.pone.0229174."},{"key":"8411_CR3","doi-asserted-by":"publisher","unstructured":"Calcaterra SL, Martin M, Bottner R, et al. Management of opioid use disorder and associated conditions among hospitalized adults: A Consensus Statement from the Society of Hospital Medicine. J Hosp Med. 2022;17(9):744-756. https:\/\/doi.org\/10.1002\/jhm.12893.","DOI":"10.1002\/jhm.12893."},{"key":"8411_CR4","doi-asserted-by":"crossref","unstructured":"Calcaterra SL, Bottner R, Martin M, et al. Management of opioid use disorder, opioid withdrawal, and opioid overdose prevention in hospitalized adults: A systematic review of existing guidelines. J Hosp Med. 2022;17(9):679-692.","DOI":"10.1002\/jhm.12908"},{"key":"8411_CR5","doi-asserted-by":"publisher","unstructured":"Alrawashdeh M, Rhee C, Klompas M, et al. Association of early opioid withdrawal treatment strategy and patient-directed discharge among hospitalized patients with opioid use disorder. J Gen Intern Med. 2023. https:\/\/doi.org\/10.1007\/s11606-023-08059-w.","DOI":"10.1007\/s11606-023-08059-w."},{"key":"8411_CR6","doi-asserted-by":"publisher","unstructured":"Bredenberg E, Tietbohl C, Dafoe A, Thurman L, Calcaterra S. Identifying factors that contribute to burnout and resilience among hospital-based addiction medicine providers: A qualitative study. J Subst Abuse Treat. 2023;144:108924. https:\/\/doi.org\/10.1016\/j.jsat.2022.108924.","DOI":"10.1016\/j.jsat.2022.108924."},{"key":"8411_CR7","doi-asserted-by":"publisher","unstructured":"Calcaterra SL, Lockhart S, Callister C, Hoover K, Binswanger IA. Opioid use disorder treatment initiation and continuation: a qualitative study of patients who received addiction consultation and hospital-based providers. J Gen Intern Med. 2022. https:\/\/doi.org\/10.1007\/s11606-021-07305-3.","DOI":"10.1007\/s11606-021-07305-3."},{"key":"8411_CR8","doi-asserted-by":"publisher","unstructured":"Englander H, Dobbertin K, Lind BK, et al. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J Gen Intern Med. 2019;34(12):2796\u20132803. https:\/\/doi.org\/10.1007\/s11606-019-05251-9.","DOI":"10.1007\/s11606-019-05251-9."},{"key":"8411_CR9","doi-asserted-by":"publisher","unstructured":"Trowbridge P, Weinstein ZM, Kerensky T, et al. Addiction consultation services - Linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1-5. https:\/\/doi.org\/10.1016\/j.jsat.2017.05.007.","DOI":"10.1016\/j.jsat.2017.05.007."},{"key":"8411_CR10","doi-asserted-by":"publisher","unstructured":"Wakeman SE, Larochelle MR, Ameli O, et al. Comparative effectiveness of different treatment pathways for opioid use disorder. JAMA Netw Open. 2020;3(2):e1920622-e1920622. https:\/\/doi.org\/10.1001\/jamanetworkopen.2019.20622.","DOI":"10.1001\/jamanetworkopen.2019.20622."},{"key":"8411_CR11","doi-asserted-by":"crossref","unstructured":"Tierney HR, Rowe CL, Coffa DA, Sarnaik S, Coffin PO, Snyder HR. Inpatient opioid use disorder treatment by generalists is associated with linkage to opioid treatment programs after discharge. J Addict Med. 2022;16(2):169-176.","DOI":"10.1097\/ADM.0000000000000851"},{"key":"8411_CR12","doi-asserted-by":"crossref","unstructured":"Christian N, Bottner R, Baysinger A, et al. Hospital buprenorphine program for opioid use disorder is associated with increased inpatient and outpatient addiction treatment. J Hosp Med. 2021;16(6):345-348.","DOI":"10.12788\/jhm.3591"},{"key":"8411_CR13","doi-asserted-by":"publisher","unstructured":"D\u2019Onofrio G, O\u2019Connor PG, Pantalon MV, et al. Emergency department-initiated buprenorphine\/naloxone treatment for opioid dependence: a randomized clinical trial. Jama. 2015;313(16):1636-44. https:\/\/doi.org\/10.1001\/jama.2015.3474.","DOI":"10.1001\/jama.2015.3474."},{"key":"8411_CR14","doi-asserted-by":"publisher","unstructured":"Englander H, Priest KC, Snyder H, Martin M, Calcaterra S, Gregg J. A call to action: hospitalists\u2019 role in addressing substance use disorder. J Hosp Med. 2020;15(3):184-187. https:\/\/doi.org\/10.12788\/jhm.3311.","DOI":"10.12788\/jhm.3311."},{"key":"8411_CR15","unstructured":"U.S. Department of Justice DEA, Diversion Control Division. Title 21 Code of Federal Regulations 1306.07: Administering or dispensing of narcotic drugs. United States Drug Enforcement Administration. July 29, 2022. Updated 2020. https:\/\/www.govinfo.gov\/content\/pkg\/CFR-1998-title21-vol9\/xml\/CFR-1998-title21-vol9-sec1306-07.xml. Accessed 8 Aug 2023."},{"key":"8411_CR16","doi-asserted-by":"publisher","unstructured":"Martin M, Englander H, Calcaterra SL. Things We Do for No Reason\u2122: Avoiding methadone for opioid withdrawal. J Hosp Med. 2023. https:\/\/doi.org\/10.1002\/jhm.13138.","DOI":"10.1002\/jhm.13138."},{"key":"8411_CR17","unstructured":"Substance Abuse and Mental Health Services Administration. Federal Guidelines for Opioid Treatment Programs. HHS Publication No. (SMA) XX-XXXX. Rockville, MD: Substance Abuse and Mental Health Services Administration, 2015."},{"key":"8411_CR18","doi-asserted-by":"publisher","unstructured":"Larochelle MR, Bernson D, Land T, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137-145. https:\/\/doi.org\/10.7326\/m17-3107.","DOI":"10.7326\/m17-3107."},{"key":"8411_CR19","doi-asserted-by":"publisher","unstructured":"Hoover K, Lockhart S, Callister C, Holtrop JS, Calcaterra SL. Experiences of stigma in hospitals with addiction consultation services: A qualitative analysis of patients\u2019 and hospital-based providers\u2019 perspectives. J Subst Abuse Treat. 2022;138:108708. https:\/\/doi.org\/10.1016\/j.jsat.2021.108708.","DOI":"10.1016\/j.jsat.2021.108708."},{"key":"8411_CR20","doi-asserted-by":"crossref","unstructured":"Calcaterra S, Bach P, Chadi A, et al. Methadone matters: what the United States can learn from the global effort to treat opioid addiction. J Gen Intern Med. 2019;34(6):1039-1042.","DOI":"10.1007\/s11606-018-4801-3"},{"key":"8411_CR21","doi-asserted-by":"publisher","unstructured":"Joudrey PJ, Chadi N, Roy P, et al. Pharmacy-based methadone dispensing and drive time to methadone treatment in five states within the United States: A cross-sectional study. Drug Alcohol Depend. 2020;211:107968. https:\/\/doi.org\/10.1016\/j.drugalcdep.2020.107968.","DOI":"10.1016\/j.drugalcdep.2020.107968."},{"key":"8411_CR22","doi-asserted-by":"publisher","unstructured":"Joudrey PJ, Edelman EJ, Wang EA. Drive times to opioid treatment programs in urban and rural counties in 5 US States. JAMA. 2019;322(13):1310-1312. https:\/\/doi.org\/10.1001\/jama.2019.12562.","DOI":"10.1001\/jama.2019.12562."},{"key":"8411_CR23","doi-asserted-by":"publisher","unstructured":"Davis CS, Carr DH. Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States. Int J Drug Policy. 2019;73:42-48. https:\/\/doi.org\/10.1016\/j.drugpo.2019.07.006.","DOI":"10.1016\/j.drugpo.2019.07.006."},{"key":"8411_CR24","doi-asserted-by":"publisher","unstructured":"Tierney HR, Takimoto SW, Azari S, Steiger S, Martin M. Predictors of Linkage to an opioid treatment program and methadone treatment retention following hospital discharge in a safety-net setting. Subst Use Misuse. 2023;58(9):1172-1176. https:\/\/doi.org\/10.1080\/10826084.2023.2212070.","DOI":"10.1080\/10826084.2023.2212070."},{"key":"8411_CR25","doi-asserted-by":"publisher","unstructured":"Calcaterra SL, McBeth L, Keniston AM, Burden M. The development and implementation of a hospitalist-directed addiction medicine consultation service to address a treatment gap. J Gen Intern Med. 2022;37(5):1065-1072. https:\/\/doi.org\/10.1007\/s11606-021-06849-8.","DOI":"10.1007\/s11606-021-06849-8."},{"key":"8411_CR26","unstructured":"University of Colorado SoM, Department of Psychiatry. Addiction Research and Treatment Services (ARTS). 2022. https:\/\/www.artstreatment.com\/. Accessed 8 Aug 2023."},{"key":"8411_CR27","doi-asserted-by":"publisher","unstructured":"Davis CS, Carr DH. Legal and policy changes urgently needed to increase access to opioid agonist therapy in the United States. Int J Drug Policy. 2019\/11\/01\/ 2019;73:42\u201348. https:\/\/doi.org\/10.1016\/j.drugpo.2019.07.006.","DOI":"10.1016\/j.drugpo.2019.07.006."},{"key":"8411_CR28","unstructured":"Request for Exception to Limitations on Dispensing for OUD (2023). https:\/\/www.deadiversion.usdoj.gov\/drugreg\/Instructions-to-request-exception-to-21-CFR%201306.07(b)-3-day-rule-(EO-DEA248R1).pdf."},{"key":"8411_CR29","unstructured":"Steadman PYD. SB16-202: Increasing Access Effective Substance Use Services. In: 73rd General Assembly CGA, editor. SB16-202. Denver, Colorado, 2016. p. 5. https:\/\/leg.colorado.gov\/bills\/sb16-202."},{"key":"8411_CR30","unstructured":"Dennis M. The Global Appraisal of Individual Needs (GAIN) Progressive Approach to Assessment. https:\/\/gaincc.org\/about\/. Accessed 31 May 2023."},{"key":"8411_CR31","unstructured":"DACODS User Manual (Drug and Alcohol Coordinated Data System) (2022). https:\/\/adad.cdhs.state.co.us\/Training\/DACODS%20User%20Manual,%20revised%2012222009.pdf."},{"key":"8411_CR32","doi-asserted-by":"publisher","unstructured":"Liebschutz JM, Crooks D, Herman D, et al. Buprenorphine treatment for hospitalized, opioid-dependent patients: a randomized clinical trial. JAMA Intern Med. 2014;174(8):1369-76. https:\/\/doi.org\/10.1001\/jamainternmed.2014.2556.","DOI":"10.1001\/jamainternmed.2014.2556."},{"key":"8411_CR33","doi-asserted-by":"publisher","unstructured":"Christian N, Bottner R, Baysinger A, et al. Hospital buprenorphine program for opioid use disorder is associated with increased inpatient and outpatient addiction treatment. J Hosp Med. 2021;16(6):345-348. https:\/\/doi.org\/10.12788\/jhm.3591.","DOI":"10.12788\/jhm.3591."},{"key":"8411_CR34","doi-asserted-by":"publisher","unstructured":"Wadhera RK, Choi E, Shen C, Yeh RW, Joynt Maddox KE. Trends, causes, and outcomes of hospitalizations for homeless individuals: a retrospective cohort study. Med Care. 2019;57(1):21-27. https:\/\/doi.org\/10.1097\/mlr.0000000000001015.","DOI":"10.1097\/mlr.0000000000001015."},{"key":"8411_CR35","doi-asserted-by":"publisher","unstructured":"Glick SN, Klein KS, Tinsley J, Golden MR. Increasing heroin-methamphetamine (goofball) use and related morbidity among seattle area people who inject drugs. Am J Addict. 2021;30(2):183-191. https:\/\/doi.org\/10.1111\/ajad.13115.","DOI":"10.1111\/ajad.13115."},{"key":"8411_CR36","doi-asserted-by":"publisher","unstructured":"Korthuis PT, Cook RR, Foot CA, et al. Association of methamphetamine and opioid use with nonfatal overdose in rural communities. JAMA Network Open. 2022;5(8):e2226544-e2226544. https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.26544.","DOI":"10.1001\/jamanetworkopen.2022.26544."},{"key":"8411_CR37","doi-asserted-by":"publisher","unstructured":"Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults. JAMA Psychiatry. 2021;78(12):1329-1342. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.2588.","DOI":"10.1001\/jamapsychiatry.2021.2588."},{"key":"8411_CR38","doi-asserted-by":"publisher","unstructured":"Silverstein SM, Daniulaityte R, Getz K, Zule W. \u201cIt\u2019s crazy what meth can help you do\u201d: lay beliefs, practices, and experiences of using methamphetamine to self-treat symptoms of opioid withdrawal. Subst Use Misuse. 2021;56(11):1687-1696. https:\/\/doi.org\/10.1080\/10826084.2021.1949612.","DOI":"10.1080\/10826084.2021.1949612."},{"key":"8411_CR39","doi-asserted-by":"publisher","unstructured":"Bungay V, Malchy L, Buxton JA, Johnson J, MacPherson D, Rosenfeld T. Life with jib: A snapshot of street youth\u2019s use of crystal methamphetamine. Addict Res Theory. 2006;14(3):235\u2013251. https:\/\/doi.org\/10.1080\/16066350500270901.","DOI":"10.1080\/16066350500270901."},{"key":"8411_CR40","doi-asserted-by":"publisher","unstructured":"Ivsins A, Fleming T, Barker A, et al. The practice and embodiment of \u201cgoofballs\u201d: A qualitative study exploring the co-injection of methamphetamines and opioids. Int J Drug Policy. 2022;107:103791. https:\/\/doi.org\/10.1016\/j.drugpo.2022.103791.","DOI":"10.1016\/j.drugpo.2022.103791."}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08411-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-023-08411-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-023-08411-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T00:03:23Z","timestamp":1726358603000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-023-08411-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,15]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["8411"],"URL":"https:\/\/doi.org\/10.1007\/s11606-023-08411-0","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,15]]},"assertion":[{"value":"30 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors have no conflicts of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}